Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosisCALABRESE, M; BERNARDI, V; ATZORI, M et al.Multiple sclerosis. 2012, Vol 18, Num 4, pp 418-424, issn 1352-4585, 7 p.Article

Imagine distribution and frequency of cortical lesions in patients with multiple sclerosisCALABRESE, M; BATTAGLINI, M; GIORGIO, A et al.Neurology. 2010, Vol 75, Num 14, pp 1234-1240, issn 0028-3878, 7 p.Article

The predictive value of gray matter atrophy in clinically isolated syndromesCALABRESE, M; RINALDI, F; MATTISI, I et al.Neurology. 2011, Vol 77, Num 3, pp 257-263, issn 0028-3878, 7 p.Article

Cortical lesions in primary progressive multiple sclerosis : A 2-year longitudinal MR studyCALABRESE, M; ROCCA, M. A; GALLO, P et al.Neurology. 2009, Vol 72, Num 15, pp 1330-1336, issn 0028-3878, 7 p.Article

Widespread cortical thinning characterizes patients with MS with mild cognitive impairmentCALABRESE, M; RINALDI, F; PERINI, P et al.Neurology. 2010, Vol 74, Num 4, pp 321-328, issn 0028-3878, 8 p.Article

Evidence for relative cortical sparing in benign multiple sclerosis : a longitudinal magnetic resonance imaging studyCALABRESE, M; FILIPPI, M; ROMUALDI, C et al.Multiple sclerosis. 2009, Vol 15, Num 1, pp 36-41, issn 1352-4585, 6 p.Article